Professional Documents
Culture Documents
VF) K KZRFT X'G SG) CJFL 5T 36Gf
VF) K KZRFT X'G SG) CJFL 5T 36Gf
An AEFI that is
caused or
precipitated by
An AEFI that is
An AEFI that is a vaccine that
caused by
caused or is due to one An AEFI that is
An AEFI arising something
precipitated by or more caused by
from anxiety other than the
a vaccine due quality defects Inappropriate
about the vaccine
to one or more of the vaccine vaccine
immunization. product,
of the product handling,
immunization
inherent including its prescribing or
error or
properties of administration administration
immunization
the vaccine device as .
anxiety
product. provided by
the
manufacturer.
EXAMPLE
Failure by the EXAMPLE
EXAMPLE EXAMPLE A fever after
EXAMPLE manufacturer vaccination
Extensive Transmission Vasovagal (temporal
to
limb swelling of infection by syncope in an association)
completely
following DTP contaminated adolescent and malarial
inactivate a
vaccination. multidose following parasite
lot of
vial. vaccination. isolated from
inactivated
polio vaccine blood.
leads to cases
of paralytic
polio.
[Thiomersal,
Formaldehyde
]
vf]k kZrft\ x'g;Sg] cjfl~5t 36gf sf] k|sf/
(Adverse Events Following Immunization -AEFI)
-v_ EoflS;gsf] u'0f:t/;Fu ;DalGwt k|ltlqmof
• vf]k / vf]k lbg] ;fwg jf ;fdfu|Lsf]
u'0f:t/lxgtfsf] sf/0faf6 x'g] cjfl~5t 36gf . h:t}
vf]ksf] /ª, kl/df0f tyf cGo c:jfefljs cj:yf -lylu|
Psf], 9';L hd]sf], /fd|f];Fu g3'lng] cflb_
b]lvPdf To:tf] efonnfO{ k|of]u gu/L ;DaGwLt
lgsfodf vj/ u/L lkmtf{ ug'{kb{5 . To:t} 3f]ns,
1955- IPV-
l;l/Ghsf] xsdf 120,000klg
injected c;fdfGo
40,000 mild polio cj:yf h:t}M
200 paralysed
3f]nsdf 9';L 10 died b]lvPdf, l;l/Ghsf] vf]n
RoftLPsf] cflbdf k|of]u ug'{x'b}g .
vf]k kZrft\ x'g;Sg] cjfl~5t 36gf sf] k|sf/
(Adverse Events Following Immunization -AEFI)
-u_ vf]k sfo{qmd ;+rfngsf] q'6Laf6 x'g]
k|ltlqmof
• vf]ksf] e08f/0f, ljt/0f, tof/L -3f]Ng] / tfGg] _ / vf]k
nufpg] ;dodf x'g] q'6Laf6 pTkGg x'g] cjfl~5t
36gf . h:t} M s]xL 306fleq Hj/f] cfpg], afGtf x'g] /
kfgL h:tf] kvfnf nfUg],aRrf lzlyn ,cw{r]t / cr]t
cj:yfdf k’g -toxic shock Syndrome_], ;'O{ lbPsf]
7f+p ;'lGgg] ,kfsg] cflb .
(vf]k e08f/0f, ljt/0f tyf vf]k tof/L ubf{ /
nufpFbf ckgfOg'kg]{ ;fjwfgLnfO{ s8fOsf
;fy lgjf{x u/]df z'Godf Nofpg ;lsG5 .)
sfo{qmd ;~rfngsf] qmddf x'g;Sg] q'6Lx? q'6Lx?
• vf]k ljt/0f tyf e09f/0fsf] qmddf plrt sf]N8r]g sfod gx'g'
• EoflS;g 3f]Nbf l;l/~h÷EoflS;g k|b"lift x'g'
• EoflS;g;Fu} pknAw u/fPsf] 3f]nsn] EoflS;g g3f]Ng', 3f]ns /
EoflS;gsf] tfkqmd ;dfg gx'g'
• 3f]n]s]f EoflS;g tf]lsPsf] ;do eGbf kl5 ;Dd k|of]u ug'{
• Pp6f vf]k s]Gb|df k|of]u u/]s]f EoflS;g csf]{ vf]k s]Gb|df k|
of]u ug'{
• 7Ls tl/sfn] ;"O{ glbg'
• s'g} sf/0f af6 b'lift ePsf] vf]k k|of]u ul/of]
vf]k sfo{qmd sf] q'6L af6 x'g] AEFI af6 arfpg
• EoflS;g ;lx tfkqmddf e08f/0f ug]{,
• cfO; Kofs slG8zlgª u/L EoflS;g ljt/0f ug]{,
• ;lx 3f]nsaf6 EoflS;g tof/ ug]{,
• k|To]s efonnfO{ 3f]Ng Pp6f 3f]ns l;l/Gh k|of]u ug]{,
• P8L l;l/Ghaf6 vf]k nufpg] .
• vf]k tof/ ubf{ tyf ;]jf lbbf ;fjwfgL ckgfO{ ;'/lIft tl/sf ckgfpg]
ax' dfqf EoflS;g efon gLlt cg';f/ vf]k k|of]u ubf{
• Dofb gu'h|]sf],
• lelePd ! / @ df ePsf],
• k|To]s vf]ksf] dfqf tfGbf ;qmd0f/lxt tl/sfn] tfg]sf],
• EoflS;g efon kfgLdf g8'a]sf],
• Tf.kqmd ±@) ;]= b]lv ±*) ;]= ePsf] x'g'kb{5 .
o;/L vf]k sfo{qmd ;+rfngsf] q'6Laf6 x'g] Toxic Shock Syndrome h:tf uDeL/
vfnsf 36gfx?nfO{ lgd"{n kfg{ ;lsG5 .
vf]k kZrft\ x'g;Sg] cjfl~5t 36gf
(Adverse Events Following Immunization -AEFI)
h'g vf]k af6 o:tf] ePsf] xf], eljiodf k'g M Tof] vf]k lbg x'b}g / of] s'/f
cleefjsnfO{ atfpg' kb{5
Inj Adrenaline sf] dfqf 0.01mg/kg, / maximum dose 0.5mg
;fjwfg M of] ;"O{ Ps k6sdf )=% ld=ln= eGbf a9L lbg' x'b}g
Inj Hydrocortisone sf] pd]/ / dfqf
• ^ dlxgfeGbfsdpd]/sf afnaflnsfsf] nflu @% ldlnu|fd IM
• ^ dlxgfb]vL ^ jif{ ;Ddsfafnaflnsfsf] nflu %) ldlnu|fd IM
• ^ jif{ b]lv !@ jif{;Ddsf afnaflnsfsf] nflu !)) ldlnu|fd IM
• !@ jif{ eGbfdflysf afnaflnsfsf] nflu @)) ldlnu|fd IM
Inj Pheniramine Maleate (Avil) sf] dfqf
• ^ dlxgfeGbf sd pd]/sf afnaflnsfsf] nflu @%) dfOqmf]u|fd
k|lt s]=hL IM (250 microgram/kg IM)
• ^ dlxgfb]vL ^ jif{ ;Ddsf] afnaflnsfsf] nflu @=% ldlnu|fd
(0.5 ml. IM )
• ^ b]lv !@ jif{;Ddsf] afnaflnsfsf] nflu % ldlnu|fd (1 ml. IM )
• !@ jif{ eGbfdflysf] afnaflnsfsf] nflu !) ldlnu|fd (2 ml. IM )
gf]6M Inj. Adrenaline lbP/ lj/fdLsf] ;'wf/ ePdf
Hydrocortisone / Avil lbO{ t'?Gt k|]if0f ug{k5{ .
P=O{=Pkm=cfO{= ls6 aS;df x'g'kg]
{ cf}ifwLx?sf]
• Injection Adrenaline- 2 Ampoules
;]6
• Injection Hydrocortisone (100 mg)- 2 Vials
• Injection Pheniramine Maleate- 2 Ampoules
• Tab. Paracetamol (500 mg)- 10 Tabs
1
• Inj. Cefotaxime 250 mg – 2 vial
-
fl e t
• Normal Saline/Ringer Lactate- 1/1 bottle each
Lea
• Insulin type Disposable Syringe (having 80 units/ml graduations) - 4 pc or
c ol
• 1ml syringe (with calibrations in 10 parts, each part 0.1 ml)– 4 pc or
roto
ms
• 1ml syringe (with calibrations in 50 parts)– 4 pc or
nt P
For
• Disposable Syringe (3 ml)- 4 pc
tme
ng
• Scalp vein/Butterfly Cannula set- 2 Sets
orti
re a
Rep
• I/V Drip set with Cannula- 2 Sets
FI T
• Cotton wool and Adhesive tape- 1 Each
FI
AE
AE
Toxic Shock Syndrome sf] Aoj:yfkg
d[To'e Ps f] 5÷5}
g ldlt ÷; do
k|]if0f ePs f]; :+
yfs f]gfd ; f]lx ; do / s ]G
b| df To; k|s f/s f 36gf
36]s f] 5 -; Vof_÷5} g
k|lt j ]bg ug]{JolQm
s f]gfdM
kbM b:t vt M km
f]g g+ ldlt ÷; doM
gf]6 Mkmf/d k"0f{
?kdf el/; s ]kl5 oyf; So l56f] lhNnf -hg_ :j f:Y o s fof{
n o, If]qLo lgb]{
z gfno,
afn:j f:Yo dxfz fvfdf k7fpg] afn:j f:Y o dxfz fvf / lhNnf -hg_ :j f:Yo s fof{ n os f] K
ofS;
g÷; Dks {g= ===============================================
vf]k nufPkl5 x'g]cj fl~5t 36gf -P=O{=Pkm
=cfO{=_ s f]cg'; G
wfg km
f/d
cg'; Gwfg ubf{; a}lj j /0fx? :ki6 ; +u eg'{xf]; \ -gk'u ePdf cs f]{kfgfdf n]v Lo; }; fy /fVg'xf]; \_=o; nfO{
lkm
N8 l/kf]6{ / P=O{=Pkm =cfO{= l/kf]6{ ; +
u} km fO{n ug'{xf]; \ . P=O{=Pkm
=cfO{= l/kf]{6 ePs f] @
$ 306fleq
cg'; Gwfg ul/g'kg]{5 .
-s _ ; fwf/0f lj j /0f P=O{=Pkm
=cfO{=s ]z cfO{=l8=gDa/M
+
:j f:Yo ; +
: yfs f]gfd M lhNnfs f]gfd M
la/fdLs f]gfd y/ M
hGd ldlt M k'?if ÷ dlxnf
cleefj s s f]gfd / gft f M
la/fdLs f]k'/ f 7]ufgf Muf=lj =; =÷g=kf=s f]gfd M
j 8f g+
=M 6f]n÷ufF pM 3/ g+
=M ; Dks {km
f]g g+
=M
* EoflS; gs f]s 'g dfqf lbPs f]xf]; f]pNn]v ug]{h:t }l8=lk=l6=–x]k aL@
, kf]lnof]@OToflb
vf]k lbPs f]ldlt / P=O{=Pkm
=cfO{=; "r gf k|fK
t u/]s f]
P=O{=Pkm
=cfO{=z '? ePs f]ldlt / ; do
; do ldlt / ; do
k|of]uz fnfdf s 'g}cg'; Gwfg ul/Ps f]5< -/ut , lb; f, cflbs f]hfF
r _M 5 ÷ 5}g
olb 5 eg]s ]kQf nfu]s f]5<
kf]i6df6{d ul/Ps f]. 5 ÷ 5}g
olb 5 eg]s ]kQf nfu]s f]5<
s ]; d'bfod}uO{cg'; Gwfg yflnPs f]5< 5 ÷ 5}g
s ]vf]k ; ]; g÷vf]k s ]Gb|df vf]k lbg]t l/s f cj nf]s g ul/ cg'; Gwfg yflnPs f]5 < 5 ÷ 5}g
; f]xLefon af6 s lt hgfnfO{vf]k ; ]j f lbPs f]lyof]=====
cg'ko'QmePdf pNn]v ug'{xf]; \M Roflt Ps f]÷ Dofb u'h |]s f]÷ lgd{lns [t gePs f]
ª _ cg'; G
wfg s t f{s f]lj j /0fM
cg'; Gwfg s t f{s f]gfdM kbM ; lxM
!_
@ _
#_
of] km f/fd el/; s ]kl5 cg'; Gwfg s t f{n] lhNnf -hg_ :j f:Yo s fof{nodf / cs f]{ k|lt If]qLo
:j f:Yo lgb]{z gfno t yf afn:j f:Yo dxfz fv fdf oyf; So l56f] dfW odaf6 k7fpg' kb{5 .
k|lt j ]bgs f]cfwf/df lhNnf -hg_ :j f:Yo s fof{non]cfj Zos s fo{ug'{kb{5 .
;'/lIft efonsf !# lgodx?
vf]k k|of]u cl3 vf]ksf]N8r]g sf] cj:yf l7s
-tfkqmd±@);]=b]vL ±*) ;] df, VVM ! / @ df , Ice-pack Conditioning
ePsf] / k|b'lzt gePsf]_ ca:yfdf /x]sf] olsg ub}{ M
!= x/]s EoflS;g efon 3f]Ng gofF l;l/~h /lgl8n k|of]u
ug]{ .
@= k|of]u u/]sf] lgl8nsf] 9Ssg gnufpg] -l/Sofk gug]
{_
#= s'g} sf/0f jf6 lgl8n b'lift ePsf] z+sf nfu]df
To;nfO{ k|of]u gug]{, ˆofFlslbg]
$= vf]k nufpg' eGbf cufl8 g} w]/} j6f l;l/~hdf vf]k
e/]/ g/fVg ;fy efonsf] lasf]{df EoflS;g tfGg lgl8n
g/fVg]
%= tf]lsPsf] ;"O{ nufpg] :yfg afx]s cGoGq vf]k
=====;'/lIft efonsf !# lgodx?
&= h]=O{= vf]k 3f]n]sf] ! 306f kl5 sbflk k|
of]u gug]{ .
*= Pp6f efonsf] vf]k csf]{ efondf gld;fpg]
(= vf]k ;Fu k7fPsf] 3f]ns dfq ;f] EoflS;g
3f]Ng k|of]u ug]{ .
!)= vf]k 3f]Nbf 3f]ns / EoflS;g b'a} sldtdf !@
3+6f Ps} tfkqmddf /x]sf] z'lglZrt u/]/ dfq
vf]k 3f]Ng]
!!=vf]k ljt/0f / 9'jfgL ubf{ cfO{;Kofs sl08;lg‹
u/]sf] ;'lglZrt ug]{
!@= ;'O{ nufPsf] efudf /ut cfPdf cleefjs jf lgh
wGojfb